Dr Ali Noroozi
Higher Degree by Research Candidate
School of Pharmacy and Biomedical Sciences
College of Health
| Year | Citation |
|---|---|
| 2026 | Noroozi, A., Naik, A., Sperandio, F. F., McCulloch, C. A., & Leask, A. (2026). Radiation-induced Salivary Gland Fibrosis: Pathogenesis and Potential Targets for Therapeutic Intervention. Current Oncology Reports, 28(1), 32 pages. |
| 2024 | Tangsiri, M., Hheidari, A., Liaghat, M., Razlansari, M., Ebrahimi, N., Akbari, A., . . . Rahdar, A. (2024). Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (EMT). Biomedicine & Pharmacotherapy, 170, 115973. |
| 2023 | Norouzi, A., Liaghat, M., Bakhtiyari, M., Noorbakhsh Varnosfaderani, S. M., Zalpoor, H., Nabi-Afjadi, M., & Molania, T. (2023). The potential role of COVID-19 in progression, chemo-resistance, and tumor recurrence of oral squamous cell carcinoma (OSCC). Oral Oncology, 144, 106483. |
| - | Norouzi, A., Davodabadi, F., Noorbakhsh Varnosfaderani, S. M., & Zalpoor, H. (2023). The potential role of acid ceramidase in oral squamous cell carcinoma chemo-resistance by inducing autophagy. Human Cell, 36(6), 2273-2275. |
| - | Zalpoor, H., Akbari, A., Nabi-Afjadi, M., Norouzi, A., Seif, F., & Pornour, M. (2023). Purinergic P2X7 Receptor as a Potential Targeted Therapy for COVID-19-associated Lung Cancer Progression. Journal of Cellular Signaling, 4(1), 21-25. |
| - | Shadab, A., Farokhi, S., Fakouri, A., Mohagheghzadeh, N., Noroozi, A., Razavi, Z. S., . . . Mahjoor, M. (2025). Hydrogel-based nanoparticles: revolutionizing brain tumor treatment and paving the way for future innovations. European Journal of Medical Research, 30(1). |
Adelaide University Research Scholarship 2026